# ArriVent BioPharma, Inc.: Form 8-K/A, filed Jul 9, 2024

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: 8-K/A
- Filed: 2024-07-09
- Accepted by EDGAR: Jul 9, 2024, 17:03 ET
- Period: 2024-04-20
- Accession: 0001104659-24-078585
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078585/tm2419108-1_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465924078585/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465924078585/tm2419108-1_8ka.htm

Filed Jul 9, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-078585. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.